Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03034434
Other study ID # 0154-16-RMB
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 14, 2017
Est. completion date June 30, 2020

Study information

Verified date July 2020
Source Rambam Health Care Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Patients after vaginal delivery will undergo 3 trans-vaginal ultrasounds in order to examine the process of cervical recuperation post delivery.


Description:

Patients after vaginal delivery will be recruited after receiving a full explanation and signing an informed consent.

The goal of the study is to examine cervical length after vaginal delivery at 3 different time intervals:

1. 8 hours post delivery.

2. 24 hours post delivery.

3. 48 hours post delivery. At each interval a trans-vaginal ultrasound will be performed, evaluating cervical length. At the end of the 3rd and final ultrasound, the patient will finish her participation in the study/ Information regarding obstetric conditions such as labor induction, gestational age at the time of delivery etc. will be collected from patients` electronic files.


Recruitment information / eligibility

Status Completed
Enrollment 1384
Est. completion date June 30, 2020
Est. primary completion date February 29, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 44 Years
Eligibility Inclusion Criteria:

- Any patient after vaginal delivery.

Exclusion Criteria:

- Any patient after cesarean section.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Trans-vaginal ultrasound
Three trans-vaginal ultrasounds, the 1st to be performed 8 hours post delivery, the 2nd 24 hours after delivery and the 3rd 48 hours after delivery.

Locations

Country Name City State
Israel Rambam health care campus Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cervical length after vaginal delivery. Measurement of cervical length 8, 24, 48 hours after vaginal delivery by trans-vaginal ultrasound. Up to 48 hours post delivery.
Secondary Differences in cervical length after vaginal delivery. Differences in cervical length after vaginal delivery as a factor of gestational age at delivery, means of labor induction, parity, etc. Up to 48 hours post delivery.
See also
  Status Clinical Trial Phase
Completed NCT01605656 - A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women N/A
Withdrawn NCT00298064 - Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer N/A
Completed NCT04413890 - Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor Phase 2
Terminated NCT00250055 - Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue N/A